The Everolimus-Transplant Exit Strategy Trial (E-TEST)
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
The Everolimus-Transplant Exit Strategy Trial (E-TEST) is a clinical trial[1].
Key Facts
- The Everolimus-Transplant Exit Strategy Trial (E-TEST) is in the country of United States[2].
- The Everolimus-Transplant Exit Strategy Trial (E-TEST)'s instance of is recorded as clinical trial[3].
- The Everolimus-Transplant Exit Strategy Trial (E-TEST)'s start time is recorded as +2013-06-30T00:00:00Z[4].
- The Everolimus-Transplant Exit Strategy Trial (E-TEST)'s end time is recorded as +2014-05-31T00:00:00Z[5].
- The Everolimus-Transplant Exit Strategy Trial (E-TEST)'s contributor to the creative work or subject is recorded as Novartis[6].
- The Everolimus-Transplant Exit Strategy Trial (E-TEST)'s number of participants is recorded as {'unit': '1', 'amount': '+1'}[7].
- The Everolimus-Transplant Exit Strategy Trial (E-TEST)'s title is recorded as Zortress (Everolimus) to Prevent Alloantibody Formation in Patients With Late Stage Renal Allograft Failure: The Everolimus-Transplant Exit Strategy Trial (E-TEST)[8].
- The Everolimus-Transplant Exit Strategy Trial (E-TEST)'s short name is recorded as E-TEST[9].
- The Everolimus-Transplant Exit Strategy Trial (E-TEST)'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
- The Everolimus-Transplant Exit Strategy Trial (E-TEST)'s ClinicalTrials.gov ID is recorded as NCT01636466[11].
- The Everolimus-Transplant Exit Strategy Trial (E-TEST)'s maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}[12].
- The Everolimus-Transplant Exit Strategy Trial (E-TEST)'s research intervention is recorded as sirolimus[13].
- The Everolimus-Transplant Exit Strategy Trial (E-TEST)'s clinical trial phase is recorded as phase III clinical trial[14].
- The Everolimus-Transplant Exit Strategy Trial (E-TEST)'s research site is recorded as Emory University[15].
- The Everolimus-Transplant Exit Strategy Trial (E-TEST)'s study type is recorded as interventional study[16].